[MOL] Re: Malignant Lymphoma [01812] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] Re: Malignant Lymphoma







VELA-OJEDA J, Tripp-Villanueva F, Montiel-Cervantes L, et al.
> Prospective randomized clinical trial comparing high-dose ifosfamide +
GM-CSF
> vs high-dose cyclophosphamide + GM-CSF for blood
> progenitor cell mobilization.
> Bone Marrow Transplant 2000;25:1141-6.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10849526&aid=B120230&dopt=r&s=lym
>
> YU J, Leisenring W, Fritschle W, et al.
> Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500
> predicts final CD34+ cell yield in the apheresis collection.
> Bone Marrow Transplant 2000;25:1157-64.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10849528&aid=B120230&dopt=r&s=lym
>
> DYSON PG, Horvath N, Joshua D, et al.
> CD34+ selection of autologous peripheral blood stem cells for
transplantation
> following sequential cycles of high-dose therapy and
> mobilization in multiple myeloma.
> Bone Marrow Transplant 2000;25:1175-84.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10849530&aid=B120230&dopt=r&s=lym
>
> LOUIE AD, Robison LL, Bogue M, Hyde S, Forman SJ, Bhatia S.
> Validation of self-reported complications by bone marrow transplantation
> survivors.
> Bone Marrow Transplant 2000;25:1191-6.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10849532&aid=B120230&dopt=r&s=lym
>
> METAYER C, Lynch CF, Clarke EA, et al.
> Second cancers among long-term survivors of Hodgkin's disease diagnosed
> in childhood and adolescence.
> J Clin Oncol 2000;18:2435-43.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10856104&aid=B120230&dopt=r&s=lym
>
> FRANCISCO JA, Donaldson KL, Chace D, Siegall CB, Wahl AF.
> Agonistic properties and in vivo antitumor activity of the anti-CD40
antibody
> SGN-14.
> Cancer Res 2000;60:3225-31.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10866315&aid=B120230&dopt=r&s=lym
>
> MAGNI M, Di Nicola M, Devizzi L, et al.
> Successful in vivo purging of CD34-containing peripheral blood harvests
> in mantle cell and indolent lymphoma: evidence for a role of
> both chemotherapy and rituximab infusion.
> Blood 2000;96:864-869.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10910898&aid=B120230&dopt=r&s=lym
>
> POSZEPCZYNSKA E, Bagot M, Echchakir H, et al.
> Functional characterization of an IL-7-dependent CD4(+)CD8alphaalpha(+)
> Th3-type malignant cell line derived from a patient with a
> cutaneous T- cell lymphoma.
> Blood 2000;96:1056-1063.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10910922&aid=B120230&dopt=r&s=lym
>
> MACH N, Gillessen S, Wilson SB, Sheehan C, Mihm M, Dranoff G.
> Differences in dendritic cells stimulated in vivo by tumors engineered to
> secrete granulocyte-macrophage colony-stimulating factor
> or Flt3- ligand.
> Cancer Res 2000;60:3239-46.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10866317&aid=B120238&dopt=r&s=mel
>
> WAN Y, Bramson J, Pilon A, Zhu Q, Gauldie J.
> Genetically modified dendritic cells prime autoreactive T cells through
> a pathway independent of CD40L and interleukin 12:
> implications for cancer vaccines.
> Cancer Res 2000;60:3247-53.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10866318&aid=B120238&dopt=r&s=mel
>
> KIRKWOOD JM, Mascari RA, Edington HD, et al.
> Analysis of therapeutic and immunologic effects of R(24) anti-GD3
monoclonal
> antibody in 37 patients with metastatic melanoma.
> Cancer 2000;88:2693-702.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10870051&aid=B120238&dopt=r&s=mel
>
> NALDI L, Lorenzo Imberti G, Parazzini F, Gallus S, La Vecchia C.
> Pigmentary traits, modalities of sun reaction, history of sunburns, and
> melanocytic nevi as risk factors for cutaneous malignant
> melanoma in the Italian population: results of a collaborative
case-control
> study.
> Cancer 2000;88:2703-10.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10870052&aid=B120238&dopt=r&s=mel
>
> MCKENNA DB, Doherty VR, McLaren KM, Hunter JA.
> Malignant melanoma and lymphoproliferative malignancy: is there a shared
> aetiology?
> Br J Dermatol 2000;143:171-173.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10886155&aid=B120238&dopt=r&s=mel
>
> CURIEL-LEWANDROWSKI C, Demierre MF.
> Advances in specific immunotherapy of malignant melanoma.
> J Am Acad Dermatol 2000;43:167-188.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10906637&aid=B120238&dopt=r&s=mel
>
> ROETZHEIM RG, Pal N, Van Durme DJ, et al.
> Increasing supplies of dermatologists and family physicians are associated
> with earlier stage of melanoma detection.
> J Am Acad Dermatol 2000;43:211-218.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10906640&aid=B120238&dopt=r&s=mel
>
> ZHOU R, Bansal N, Leeper DB, Glickson JD.
> Intracellular acidification of human melanoma xenografts by the
respiratory
> inhibitor m-iodobenzylguanidine plus hyperglycemia: a
> 31P magnetic resonance spectroscopy study.
> Cancer Res 2000;60:3532-6.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10910065&aid=B120238&dopt=r&s=mel
>
> MORTARINI R, Borri A, Tragni G, et al.
> Peripheral burst of tumor-specific cytotoxic T lymphocytes and
infiltration
> of metastatic lesions by memory CD8+ T cells in melanoma
> patients receiving interleukin 12.
> Cancer Res 2000;60:3559-68.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10910069&aid=B120238&dopt=r&s=mel
>
> JAGER D, Stockert E, Jager E, et al.
> Serological cloning of a melanocyte rab guanosine 5'-triphosphate- binding
> protein and a chromosome condensation protein from a
> melanoma complementary DNA library.
> Cancer Res 2000;60:3584-91.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10910072&aid=B120238&dopt=r&s=mel


------------------------------------------------------------------------
This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------